Search Results 1991-2000 of 25052 for oral
Subjects currently receiving oral anticoagulants (ie, warfarin/other vitamin K antagonists or direct-acting oral anticoagulants \[DOACs\]) if any of the ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Surgery · Thoracic Surgery. Areas that research ...
A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...
... oral ibrexafungerp is non-inferior to IV echinocandin followed by oral fluconazole based on 30-day all-cause mortality (ACM). Furthermore, to demonstrate ...
Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era. Int J Cardiol Heart Vasc ...
Oral corticosteroids. These medicines taken by mouth help ease lung inflammation. They're used only when asthma can't be controlled with other treatments ...
Oral antivirals may take one to two days off of the duration of an outbreak. If you have eczema or a weakened immune system, you may be prone to more ...
Recipient, Best Oral Presentation Award, Stanford Neuroscience Forum, 2014; Recipient, Edwin Boldrey Award for Neuroscience, San Francisco Neurological ...
Oral metronidazole;; Oral sulfasalazine;; Oral retinoid. Exclusion Criteria: Subjects fulfilling any of the following criteria are not eligible for inclusion ...
... (oral, intravaginal, or transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.